Navigation Links
Novus Biologicals Hires David Eansor to Lead New Corporate-Development Effort
Date:1/24/2013

LITTLETON, Colo., Jan. 24, 2013 /PRNewswire/ -- Novus Biologicals LLC, a leading provider of antibodies and reagents to the life science research community, has hired David Eansor to lead a new corporate-development effort.

Eansor, a 13-year veteran in the life science market who was most recently the president of Thermo Fisher Scientific's bioscience division, joined Novus in January as senior vice-president of corporate development. In this new role, Eansor is tasked with accelerating Novus' already impressive growth through a combination of organic investments, licensing and acquisitions of complementary products and capabilities.

"I'm thrilled to join Novus, and for the opportunity to create new growth platforms for this innovative company," Eansor said. "I have watched Novus grow from a niche player to a leader in its space, and I've always been impressed with its commitment to scientific research and outstanding customer service."

"We are so pleased to have an executive of David's caliber join our team, and look forward to many stellar contributions as he expands this critical corporate-development function for us," added Karen Padgett , Novus' founder and chief executive.

Before becoming president of the bioscience division of Thermo Fisher , a publicly traded company, Eansor served as president of the life science research division, acquiring three businesses during his tenure.

Prior to that, he was president of Cambrex Bioproducts, another life science research business focused on cell biology. Eansor also spent 19 years with R.P Scherer Corp., a contract pharmaceutical drug-delivery manufacturer which was acquired by Cardinal Health. He holds a degree in chemistry from the University of Western Ontario as well as a bachelor of commerce and an MBA from the University of Windsor, also in Ontario, Canada.

About Novus

Novus Biologicals is a leading digital marketing-driven, life science company that supplies antibodies and reagents to the $6 billion global proteomics market.  Novus is known for its breadth of quality antibodies and reagents that are well recognized by its global customer base.  Based in Littleton, CO, the company was founded in 1996 to license, produce and market antibodies to support niche and emerging areas of research.  Now Novus is a global enterprise with a catalog of 180,000 products sold in 60 countries, mainly through its Web site. Novus is backed by Mainsail Partners, a San Francisco growth-equity firm, and has additional offices in Ontario, Canada and Cambridge, UK.

CONTACT

Karen Padgett , President and CEO

Novus Biologicals, LLC

Karen@novusbio.com

303-730-1950

www.novusbio.com


'/>"/>
SOURCE Novus Biologicals LLC
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. First Product Candidate Moving Toward Commercialization as Result of Novus International and Verenium Collaboration
2. PhoenixSongs Biologicals, Inc. Announces Enhanced Neural Lineage-specific Cell Culture Media Products Release
3. PathoGenetix Hires Food Safety Testing Expert John W. Czajka as Vice President of Business Development
4. Ganeden Biotech Hires New Marketing Manager
5. Provia Labs Hires Vice President of International Business Development to Expand Global Distribution for its Stem Cell Banking Service and Biobanking Products
6. Ernst & Young LLP Bolsters Fraud Investigation & Dispute Services with New Hires and Promotions
7. Inspiration Biopharmaceuticals Expands Industry Expertise with Five New Executive Hires
8. Textile Company PurThread Technologies Opens Headquarters in Durham, North Carolina and Hires New Senior Staff
9. Synthetic Genomics Inc. Hires Industry Leader George E. Stagnitti to Head Food and Nutritional Products Development Program
10. Zyngenia, Inc. Promotes Chief Scientific Officer and Hires Chief Business Officer
11. David Smith Named Vice President of Operations for HealthTell
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... 2016 , ... Orthogonal, a Chicago-based medical device software company, ... 510(k) clearance for their flagship medical device, SimplECG. , With this FDA approval, ... rely on cloth-based nanosensors. While other companies have attempted to focus on wearable ...
(Date:12/2/2016)... Laboratories, a world leader in rapid infectious disease tests, introduced the Company,s newest product, ... (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) Continue Reading ... ... , , bioLytical was invited by ... the INSTI HIV Self Test to 350 pharmacy representatives in Nairobi ...
(Date:11/30/2016)... RATON, Fla. , Nov. 30, 2016 ... biotherapeutic products, is pleased to announce the addition of ... Avenue Kearney, Nebraska . The 15,200 ... business on November 29th, 2016 and brings the total ... Ileana Carlisle , BPC,s Chief Executive ...
(Date:11/30/2016)... BILLERICA, Massachusetts , 30. November 2016 ... und Technologieunternehmen, hat heute die Unterzeichnung einer ... gegeben. Diesen zufolge wird Evotec AG Screeningleistungen ... und shRNA-Bibliotheken bereitstellen. Der Zugriff auf diese ... Bereich Screening eröffnet einen schnelleren Weg zur ...
Breaking Biology Technology:
(Date:11/30/2016)... -- higi SH llc (higi) announced today the launch ... industry thought-leaders and celebrity influencers looking to encourage, ... steps to live healthier, more active lives. ... built the largest self-screening health station network in ... have conducted over 185 million biometric screenings.  The ...
(Date:11/24/2016)... Nov. 23, 2016 Cercacor today introduced Ember ... their trainers non-invasively measure hemoglobin, Oxygen Content, ... and Respiration Rate in approximately 30 seconds. Smaller than ... and immediate access to key data about their bodies ... training regimen. Hemoglobin carries oxygen to ...
(Date:11/17/2016)... Market Watch: Primarily supported by ownership types; Private ... market is to witness a value of US$37.1 billion by ... Annual Growth Rate (CAGR) of 10.75% is foreseen from ... North America is not way behind ... at 9.56% respectively. Report Focus: The ...
Breaking Biology News(10 mins):